National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov

NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
NCI Drug Dictionary
Page Options
Print This Page
More NCI Dictionaries
Dictionary of Cancer Terms

Glossary of Statistical Terms

NCI Dictionary of Genetics Terms

Terminology Resources
Quit Smoking Today
Search for
# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z All

oligofructose-enriched inulin
A mixture of non-digestible carbohydrates, containing the fermentable plant fructans oligosaccharide and inulin, with potential prebiotic activity. Resisting hydrolysis by intestinal digestive enzymes, inulin and oligofructose serve as growth media and energy substrates for bifidobacteria in the colon; beneficial colonic commensal bacteria such as bifidobacteria may inhibit the colonization of the intestine by pathogenic bacteria and have been inplicated to inhibit colon carcinogenesis. Oligofructose-enriched inulin may be administered in combination with probiotic bifidobacteria. In addition, this agent may promote the absorption of calcium and magnesium from the gastrointestinal tract. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)

Synonym:Synergy 1
US brand name:Beneo Synergy 1
Foreign brand name:Beneo Synergy 1



Previous:Oestromon, ofatumumab, ofloxacin, oglufanide disodium, olanzapine
Next:oligonucleotide SPC2996, omacetaxine mepesuccinate, omeprazole, Omnitarg, Oncaspar

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov